Rationing by assumption: De-implementation of spinal injections requires rigorous comparative evidence
The Journal of Pain · 2026-08 · 45 · 106296
DOI: 10.1016/j.jpain.2026.106296 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pain, 2026-08. Verfasst von Robert W Hurley und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Anesthesiology, Translational Neuroscience, and Public Health, Pain Outcomes Lab, Wake Forest University School of Medicine, Winston S…. Hauptthemen laut MEDLINE: Low Back Pain, Injections, Spinal, Chronic Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Ballengee et al. propose an implementation science framework for de-implementing epidural steroid injections (ESIs) for chronic low back pain (CLBP). This commentary identifies several critical limitations of their proposal. First, the target population is inadequately defined; the term "non-specific" CLBP is never operationalized, inviting misapplication to patients with specific pathoanatomical diagnoses. Second, the evidentiary anchor, a recent BMJ clinical practice guideline, is subject to a formal retraction request from 34 professional organizations citing inappropriate pooling of heterogeneous procedures, data extraction errors, and violations of GRADE methodology. Third, the proposed replacement therapies (including cognitive behavioral therapy, physical therapy modalities) demonstrate comparably modest effect sizes, yet are held to a lower evidentiary standard. Fourth, indirect cost-utility comparisons do not favor de-implementation: published analyses consistently place ESIs within accepted willingness-to-pay thresholds, while behavioral alternatives carry higher cost-per-QALY ratios. Fifth, the structural incentive analysis applied to proceduralists must be applied symmetrically to the professions that would absorb redirected clinical volume. De-implementation should be held to the same evidentiary rigor as implementation, requiring head-to-head comparative effectiveness and cost-effectiveness data before removing a therapeutic modality from the clinical armamentarium. PERSPECTIVE: This commentary argues that de-implementing epidural steroid injections without head-to-head comparative effectiveness and cost-effectiveness evidence risks restricting access to a therapy that remains cost-effective and that may facilitate participation in multimodal care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Anesthesiology, Translational Neuroscience, and Public Health, Pain Outcomes Lab, Wake Forest University School of Medicine, Winston Salem, NC, United States. Electronic address: hurleyjournalwork@gmail.c…
- Department of Physical Medicine and Rehabilitation, University of Utah School of Medicine, Salt Lake City, UT, United States.
- Departments of Anesthesiology, Neurology, Physical Medicine & Rehabilitation, Psychiatry, and Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, United States; Walter Reed National M…
Förderung
- National Institutes of Health
Zitieren
APA
Hurley, R. W., McCormick, Z. L., & Cohen, S. P. (2026). Rationing by assumption: De-implementation of spinal injections requires rigorous comparative evidence. The Journal of Pain, 45, 106296. https://doi.org/10.1016/j.jpain.2026.106296
Vancouver
Hurley RW, McCormick ZL, Cohen SP. Rationing by assumption: De-implementation of spinal injections requires rigorous comparative evidence. The Journal of Pain. 2026;45:106296. doi:10.1016/j.jpain.2026.106296
BibTeX
@article{Hurley2026,
author = {Hurley, Robert W and McCormick, Zachary L and Cohen, Steven P},
title = {Rationing by assumption: De-implementation of spinal injections requires rigorous comparative evidence},
journal = {The Journal of Pain},
year = {2026},
volume = {45},
pages = {106296},
doi = {10.1016/j.jpain.2026.106296}
}
EUVIMED